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Wednesday, February 11, 2015 593aby switches of myosin isoforms from IIa to IIx and IIb, with no change in type I
myosin, and to more low molecular weight fast troponin T splice forms. During
reloading, soleus muscle mass, fiber size and contractile force gradually recov-
ered and reached the control level by 15 days. The levels of type IIa, IIx and IIb
myosins recovered at 15 days of reloading. However, fatigue tolerance and post
fatigue force recovery showed a trend of worsening during this period with
significantly inflammatory cell infiltration at 3 and 7 days, indicating reloading
injuries. The reloading injury was accompanied by up-regulations of filamin-C
and alpha-crystallin-B, which returned to control level after 30 days. During the
course of slow recovery, we observed later increases of type I myosin expres-
sion and the number of type I fibers to levels significantly higher than that in
normal adult mouse soleus muscle at 30 to 60 days of reloading, which may
contribute to the recovery of fatigue tolerance. The data demonstrated the value
of increased slow fiber contents as a secondary adaption to compensate for mus-
cle reloading injury, serving as an indicator for monitoring muscle function dur-
ing the chronic recovery from unloading and disuse conditions.
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Myosin II is an ensemble motor that participates in muscle contraction, actin
cortex remodeling and cytokinesis ring constriction. It has been an interesting
puzzle for scientific community to understand the allosteric rules between
motors that regulate/co-ordinate when they work in group. We have performed
classical In Vitromotility assay at different heavy meromyosin (HMM) density
and ATP concentrations. By changing immobilized HMM density and ATP
concentration, we change the number of HMMmolecules available for interac-
tion/unit length of actin filament. Actin filaments of >10 micron length were
added in flow cell and assay was initiated by addition of ATP. Actin filaments
breaks down to smaller pieces within minutes after addition of ATP. Average
length of sliding filaments correlates well with motors density and ATP con-
centrations in solution. At 633 head/mm2 density and 2 mM ATP concentration
the average filament length was 1747.65614 nm and further reduced to
1290.55385.5 nm at 0.1 mM ATP. At 4000 heads/mm2 density and 2 mM
ATP concentration the average filament length was 935.55286 nm and
reduced to 599.55154.2 nm at 0.1 mM ATP. Any filament below this average
length does not slide continuously, they detach from surface with time and any
filament above this average length fragments to smaller pieces with time.
Assuming Poisson distribution of immobilized heads, we calculated maximum
number of molecules that can interact for a given actin length. Number of mol-
ecules required for continuous sliding is independent of motor density and de-
pends only on ATP concentration. For 2 mM ATP concentration, 123.6528.9
heads and for 0.1 mM ATP concentration 62.3 519.5 heads are required for
continuous sliding of actin. All values are mean 5 SD.
Supported by DST, Government of India.
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The myosin converter has been proposed to be critical for setting muscle short-
ening velocity by influencing the amplification of small conformational changes
at the ATPase site into the larger lever arm swing. To test this hypothesis, we
exploited the natural variation of the converter region found inDrosophilamus-
cle types. In Drosophila, a single myosin heavy chain gene is alternatively
spliced to generate myosin isoforms. The converter region is encoded by five
alternative versions of exon 11 that are expressed in different muscle types.
Through genetic modification we forced the expression of the alternative ver-
sions in the Drosophila jump muscle and found that two of the three versions
tested to date, 11a (native to indirect flight muscles) and 11e (embryonic mus-
cles), caused faster maximum shortening velocities of skinned jump muscle fi-
bers relative to the native control 11c. Increases in velocity were primarily
responsible for 70.9% and 79.0% higher power outputs for 11a and 11e fibers,
respectively, because maximum force generation was not significantly different
from control fibers. The fibers expressing 11a and 11e also exhibited a straighter
force-velocity curve, as shown by increased Hill equation parameters a (95.4%
and 84.5% higher, respectively) and b (72.6% and 65.5% higher, respectively)
relative to control fibers, indicating that the converter modulates load dependentcross-bridge kinetics. The higher power and shortening velocity of 11a and 11e
fibers enabled increased jumping ability, 76.0% and 48.8% farther, respectively.
Converter homology models, using the new Drosophila myosin S1 crystal
structure (pdb 4QBD), revealed minimal tertiary structure differences suggest-
ing residue specific interactions with the relay, N-terminus, or essential light
chain are critical. Overall, our data support the hypothesis that the converter
helps set muscle shortening velocity under loaded and unloaded conditions
and thus contributes to muscle fiber type diversity.
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Actin filaments carry out diverse cellular functions including cell division,
intracellular transport, and muscle contraction. Tropomyosin (Tm) is an a-he-
lical coiled-coil protein that regulates actin in most eukaryotic muscle and non-
muscle cells. Nonmuscle isoforms of Tm, particularly Tm5NM1 (Tpm3.1)
(short isoform, 247 a.a., TPM3 gene), play an important role in cellular func-
tions such as cell migration, and cytokinesis as well as in the transformation
and metastasis of cancer cells. In previous work, mutation of evolutionarily-
conserved residues in striated muscle aTm (Tpm1.1) (long isoform, 284 a.a.,
TPM1 gene) revealed the regions important for actomyosin regulation. In the
present study, we have mutated evolutionarily-conserved residues in Tpm3.1
to determine the molecular basis for isoform-specificity of actomyosin regu-
lation by Tms. We mutated surface residues in nonmuscle Tpm3.1 in periods
P1-P7 at positions homologous to the residues that are important for actomy-
osin regulation by striated muscle Tpm1.1 (Barua et al., 2012). In vitro motility
assays were carried out to determine the effect of mutations on actin filament
velocities. Actin-Tm velocities with skeletal myosin are inhibited by Tpm1.1
(~60%) but activated by Tpm3.1 (~60%) relative to actin alone. The Tpm3.1
mutants had little or no effect on velocity, except for the P3 and P6 mutants
that showed a ~50-60% inhibition in filament velocity relative to WT
Tpm3.1. In comparison, amongst the Tpm1.1 mutants, the P3 and P6 mutants
also showed the largest inhibition (~70-80%) in filament velocity relative to
WT Tpm1.1. These results indicate that the same regions of Tm (periods 3
and 6) are important for regulation of skeletal myosin by two different isoforms
that have contrasting effects (inhibition by Tpm1.1 vs. activation by Tpm3.1)
on filament velocity. Supported by NIH.
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Striated muscle tropomyosin is phosphorylated at a single site. Effects of this
covalent modification include an increase in myosin activation by thin fila-
ments (þCa(II)) under steady state conditions (Vmax, 16 vs. 8 sec-1; ionic
strength, ~ 30 mM; T, 25 oC). Thin filaments were assembled using skeletal
muscle troponin and alpha-tropomyosin (either unphosphorylated or phosphor-
ylated). Each type of thin filament was mixed with varying concentrations of
myosin-S1A1 (4uM F-actin; buffer, 5.5 mMMgCl2, 50 mM KCl, 10mM imid-
azole, 3mM MgADP, 1mM dithiothreitol, pH 7 plus 0.5mM EGTA or Ca(II))
and incubated at 4 oC for 1hr with 20uM myokinase inhibitor. The mixtures
were then centrifuged for 30min at 150,000 x g at 25 oC. The unbound S1
was determined using a NH4/EDTA ATPase versus [myosin-S1A1] standard
curve. The zero time samples showed no colour development, consistent
with the absence of ATP. At a given pCa the isotherms obtained with each
type of reconstituted thin filament are virtually superimposable (in terms of
steepness and mid-point). The apparent binding constants range from 0.1 to
0.4 uM. Added Ca(II) strengthens affinity and EGTA weakens it. Pre-steady
state experiments using double-mixing fluorescent stopped-flow are in progress
to investigate further the effect of this modification.
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Mutations in cardiac troponin C (cTnC) have been linked to hypertrophic car-
diomyopathy (HCM) in humans. The cTnC subunit of the troponin complex is
594a Wednesday, February 11, 2015expressed in both slow skeletal and cardiac muscle. The cTnC HCM muta-
tions A8V, C84Y and D145E increase the Ca2þ-sensitivity of contraction in
cardiac muscle; however, their functional consequences in slow skeletal mus-
cle regulation are unknown. Here we investigated the Ca2þ-sensitivity of
TnC-extracted rabbit soleus skinned fibers reconstituted with either WT or
HCM mutant cTnC. Surprisingly, the slow skeletal skinned fibers extin-
guished the Ca2þ-sensitization typical of cardiac fibers for A8V (pCa50 ¼
6.01) and D145E (pCa50 ¼ 6.05), while for C84Y (pCa50 ¼ 6.33) the
Ca2þ-sensitization was maintained compared to WT (pCa50 ¼ 6.00). To deter-
mine whether slow skeletal TnI (ssTnI) alone was responsible for the protec-
tive effect of incorporating the A8V and D145E mutants into the slow skeletal
myofilaments, cardiac skinned fibers were reconstituted with a hybrid cardiac
troponin complex containing cTnT, ssTnI and cTnC-WT or -HCM mutants.
The presence of ssTnI in cardiac fibers partially protected against Ca2þ-sen-
sitization by the cTnC mutants in cardiac skinned fibers, with the exception
of C84Y. MgATPase activity of slow or cardiac myofibrils replaced with
exogenous HCM cTnC mutants were also affected. The absence of increased
Ca2þ-sensitivity of contraction arising from the A8V and D145E in the soleus
muscle suggests that the aberrant effects of cardiomyopathic cTnCs may be
tissue-specific, and ssTnI is an important partner that partially protects the
slow muscle from a deleterious effect of the HCM cTnC mutants. Supported
by NIH HL103840 (JRP).
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Missense mutations in the TNNC1 gene encoding cardiac and slow skeletal
troponin C (c/ssTnC) are associated with phenotypic outcomes of hypertrophic
cardiomyopathy (HCM). The impact of HCM c/ssTnC mutations in skeletal
muscle structure and function is unknown; therefore, we examined the effect
of an HCM-associated c/ssTnC A8V mutation on myosin heavy chain
(MHC) isoform expression, contractile properties of different skeletal muscles,
and cardiac autonomic function in a homozygous knock-in mouse (KI-TnC-
A8Vþ/þ). The distribution of MHC I/II isoforms in various muscles from
3-month old male WT and KI-TnC-A8Vþ/þ mice were analyzed by glycerol
SDS-PAGE and the muscle/body weight ratios (M/BW) were recorded. Me-
chanics of contraction in isolated intact soleus muscle, running/endurance
capacity and heart rate variability (HRV) were also measured. In comparison
to the WT mice, MHC isoform switching was observed in diaphragm
(increased MHCIIb, decreased MHCI) and soleus (decreased MHCIIa,
increased MHCI) muscles of KI-TnC-A8Vþ/þ mice; while, the M/BW ratio
was unchanged for all tested muscles. The force vs frequency relationship
at 15Hz and the t1/2 of relaxation increased in the intact soleus muscle of KI-
TnC A8Vþ/þ mice in comparison to the WT; whereas, no changes in maximal
force, time-to-twitch peak, velocity and power output were observed. In en-
durance and HRV tests, KI-TnC-A8Vþ/þmice had a lower running distance ca-
pacity and their global autonomic, cardiovagal, and baroreflex activities were
significantly reduced compared to WT. In spite of the increase in type I fibers
in soleus muscle of mice expressing c/ssTnC A8V, they display reduced endur-
ance capacity. These findings suggest that the slow skeletal muscle is trying to
compensate for the cardiac dysfunction caused by the c/ssTnC A8Vþ/þ muta-
tion. Supported by NIH HL103840 (JRP).
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We have implemented two computation versions of the solution actin-myosin
ATPase cycle. A simple numerical model that simulates an eight step
ATPase cycle and allows actin, myosin, substrate ATP and product ADP
& Pi concentrations to be fixed or varied. This model allows us to rapidly
assign realistic rate constants to each step of the cycle for any well-
defined myosin isoform. With this set of rate constants in place we canthen implement a stochastic version of the eight step ATPase cycle that in-
cludes calcium regulation of the actin binding steps according to the McKil-
lop & Geeves Blocked/Closed/Open model of the regulated thin filament.
Using this model it is now feasible to model the dependence of the ATPase
rate on calcium concentration and predict the occupancy of each state in the
cycle for any defined set of protein and substrate concentrations. This allows
us, for example, to explore the interplay of calcium and ATP concentrations
in the cooperative activation of the ATPase cycle and make predictions for
how the system will respond to sudden changes in calcium or ATP concen-
tration. In a further variant of the model the program allows us to predict how
the system will respond if variable ratios of fast and slow isoforms of
myosin, or variable ratios of proteins carrying cardiomyopathy mutations
are present in the system. This will be a useful tool to explore the behaviour
of mixed myosin & troponin populations and correlate experimental data
with model predictions.
Supported by: R01 AR048776, R01 DC 011528 and W.Trust 085309
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We have used site-directed time-resolved FRET to detect structural changes of
the N-terminal extension on the A1 isoform of ELC, during active interaction
with actin. Skeletal muscle myosin subfragment 1 (S1) has two ELC isoforms,
A1 and A2, which differ by the presence of 40-45 additional residues at the
N-terminus of A1. Removal of ELC from myosin results in a loss of movement
of actin filaments, and a reduction in isometric force. It has been proposed that
the N-terminal extension of A1 interacts directly with actin to modulate acto-
myosin kinetics. We have used time-resolved FRET to explore the structural
details of this modulation. We recently showed, using probes on actin and
ELC, that the amplitude of the myosin power stroke is much greater for A1
than A2. We have now engineered single cysteine (C16, in the N-terminal
extension) and double cysteine (C16-C180, in the C-terminal lobe) mutants
of A1-ELC and used FRET to determine the distance from C16 to actin 374
or to C180, as affected by the power stroke. Labeled ELCs were exchanged
into S1, and the pure isoenzyme (S1A1) was isolated using Talon affinity resin.
Labeling and exchange preserved the functional properties of S1A1. Intermo-
lecular FRET between C374 of actin and C16 of A1 showed that the distance
increases from 2.9 nm to 3.5 nm upon addition of ATP. Intramolecular FRET
between C16 and C180 does not change in the presence of ATP or actin. We
conclude that (1) the N-terminus of ELC moves away from actin during the
transition between strongly and weakly bound states of acto-S1, and (2) the
converter/C-terminal domain of myosin/ELC and the N-terminal extension
move as a rigid body during the power stroke.
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The N-terminus of vertebrate fast-type myosin light chain 1 (MLC1F) contains
a conserved actin-binding domain, a nearby poly-alanine (poly-A) domain, and
an adjacent alanine-proline (A-P) repeat domain. The number of residues in the
poly-A and A-P repeat domains vary considerably among vertebrate species.
We reported a strong correlation between the apparent mass of MLC1F and
adult body mass for nineteen mammalian species (Bicer and Reiser, Am. J.
Physiol. Regul. Integr. Comp. Physiol., 292:R527-R534, 2007). The MLC1F
sequence was then known for five of the nineteen species and the variation
in MLC1Fmass was determined to be due largely to the variation in the number
of residues in the poly-A and the number of A-P repeats among these five spe-
cies. We have recently examined the reported MLC1F sequence of additional
mammalian species and of species of other vertebrate classes to determine
the extent of the correlations between the number of poly-A residues and the
number of A-P repeats and body mass among vertebrates, with a particular in-
terest in comparing species with different modes of locomotion (e.g., terrestrial
walking/running versus swimming). We also examined the sequences of other
MLCs for the presence of systematic variations among species and possible
correlations with species body mass. The results reveal that the numbers of
poly-A residues and A-P repeats increase with species body mass among terres-
trial mammals. Furthermore, the MLC1F domains vary most consistently with
adult species body mass than any of the other examinedMLCs. The results sug-
gest that MLC1F domains are likely involved with modulating the speed and/or
economy of locomotion among terrestrial mammals.
